Connect with us

Company News

Bayer joins Manufacture 2030

“Advancing life – that’s what we at Bayer are all about.” With this strong mission statement at the core of its operations, it seems fitting that the pharmaceutical and life science company has joined Manufacture 2030 to further promote inclusive growth and responsible use of resources.

For Bayer, the concept of inclusive growth means “providing more people across the world with access to health care and food security, and devising solutions to protect the environment, especially decarbonisation, climate adaptation, and biodiversity preservation.”

Bayer’s Ambitious Series of Sustainability Commitments
In line with the United Nations Sustainable Development Goals and the Paris Agreement, Bayer’s ambitious sustainability targets to achieve by 2030 include:

  • To reduce its Scope 1 and 2 greenhouse gas (GHG) emissions by 42%, and absolute Scope 3 GHG emissions by 12%
  • By 2030 the remaining emissions of Bayer’s operations will be fully offset by purchasing certificates from verified climate protection projects

“Given CO2 emissions are the main reason for climate change, Bayer is committed to making our business as resource efficient as possible, aiming to become carbon-neutral across our own operations by 2030. By partnering with Manufacture 2030 and their cloud-based platform, the Bee, we can better equip our operational teams with the know-how needed to reduce impacts, as well as track our site-level performance towards company targets. We are confident that by embedding innovative technologies like the Bee, we can play our part in protecting the climate,” said Thomas Gosmann, Head of Pharma Technology & Global Energy Manager at Bayer.

Bayer’s Five Year Partnership with Manufacture 2030
Over the next five years, Manufacture 2030 aims to help Bayer meet its targets, reducing SCope 1 and 2 emissions across Bayer’s 138 sites, and covering all three business units.

“We are delighted to be launching this new partnership with Bayer, helping them to achieve their Science Based Targets by reducing site-level environmental impacts. Helping people and the planet is at the heart of Bayer’s philosophy, as well as being an organisation full of expertise, so we are thrilled they have chosen our unique platform to aid them in continually improving the environmental sustainability of their business,” added Martin Chilcott, Founder and CEO at Manufacture 2030. Manufacturing Global

Copyright © 2024 Medical Buyer

error: Content is protected !!